A bioengineering method for modeling alveolar Rhabdomyosarcoma and assessing chemotherapy responses
Autor: | David L. Perrin, Ehsan Samiei, Mohammad Esmaeillou, Arya Emami, Saeid Ghavami, Mohsen Akbari, Joseph W. Gordon, Kiarash Roustai Geraylow, Mahboubeh Kavoosi, Evan Stefanek, Milad Ashrafizadeh |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
DFS
Disease-free survival Clinical Biochemistry Apoptosis MYOD1 Myogenic muscle differentiation transcription factor 1 Biofabrication Extracellular matrix DNA Deoxyribonucleic acid 0302 clinical medicine Rhabdomyosarcoma Medicine RPMI Roswell Park Memorial Institute PDMS Polydimethylsiloxane RGD Arginylglycylaspartic acid 0303 health sciences IgG Immunoglobulin G RMS Rhabdomyosarcoma DAPI 4’ 6-Diami- dino-2-Phenylindole Dihydrochloride EDTA Ethylenediaminetetraacetic acid Primary tumor EM Engineered model PAX Paired box gene AKT Protein Kinase B 3. Good health Medical Laboratory Technology HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 030220 oncology & carcinogenesis Alveolar rhabdomyosarcoma Protocol Article Cell death EthD-1 Ethidium homodimer-1 Programmed cell death 3D Three-dimensional Science dECM Decellularized extracellular matrix 2D Two-dimensional MEK Mitogen-activated extracellular signal-regulated kinase FOXO1 Forkhead box protein O1 03 medical and health sciences BSA Bovine serum albumin ECM Extracellular matrix In vivo RT Room temperature DMEM Dulbecco's phosphate buffered saline Autophagy 030304 developmental biology business.industry ICC Immunocytochemistry LC3 Microtubule associated protein 1A/1B-light chain 3 PNIPAAm Poly-N-isopropylacrylamide medicine.disease Cell culture TMZ Temozolomide FBS Fetal bovine serum Cancer research business |
Zdroj: | MethodsX, Vol 8, Iss, Pp 101473-(2021) MethodsX |
ISSN: | 2215-0161 |
Popis: | Rhabdomyosarcoma (RMS) is the most common pediatric soft-tissue malignant tumor. Treatment of RMS usually includes primary tumor resection along with systemic chemotherapy. Two-dimensional (2D) cell culture systems and animal models have been extensively used for investigating the potential efficacy of new RMS treatments. However, RMS cells behave differently in 2D culture than in vivo, which has recently inspired the adoption of three-dimensional (3D) culture environments. In the current paper, we will describe the detailed methodology we have developed for fabricating a 3D engineered model to study alveolar RMS (ARMS) in vitro. This model consists of a thermally cross-linked collagen disk laden with RMS cells that mimics the structural and bio-chemical aspects of the tumor extracellular matrix (ECM). This process is highly reproducible and produces a 3D engineered model that can be used to analyze the cytotoxicity and autophagy induction of drugs on ARMS cells. The most improtant bullet points are as following:•We fabricated 3D model of ARMS.•The current ARMS 3D model can be used for screening of chemotherapy drugs.•We developed methods to detect apoptosis and autophagy in ARMS 3D model to detect the mechansims of chemotherapy agents. Graphical abstract Rhabdomyosarcoma (RMS) is the most common pediatric soft-tissue malignant tumor. Despite numerous clinical trials that have investigated the efficacy of multidrug chemotherapy regimens, outcomes for high-risk RMS patients are still poor which has inspired research into new targeted therapies that molecularly target malignant RMS cells. In order to evaluate such therapies in vitro in a realistic tumor microenvironment, we have bioengineered a cell-laden 3D tissue-engineered model with uniform geometry and an uncomplicated and reproducible biofabrication process. The transparent collagen-I hydrogel promotes cell attachment and growth and allows for analysis of the cellular response to drugs through brightfield microscopy, immunocytochemistry, and live/dead viability assays.Image, graphical abstract |
Databáze: | OpenAIRE |
Externí odkaz: |